A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.

PLoS Pathog · 2022 · PMC9779650 · PMID 36508467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

All 3 reviewers stated that the authors satisfactorily addressed previous comments, and that this work is highly significant towards tackling SAR-CoV-2 variants.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.